Introduction {#Sec1}
============

The burden of obesity in women of reproductive age is increasing worldwide, particularly in low/middle-income countries. In China, about 14% of women of reproductive age were obese in 2008 \[[@CR1]\], and likely worsening thereafter \[[@CR2]\]. Maternal obesity increases the risk of various adverse pregnancy outcomes \[[@CR3]\] and can affect offspring health \[[@CR4], [@CR5]\]. Previous studies showed that maternal obesity had been linked to maternal anemia \[[@CR6], [@CR7]\] and iron deficiency \[[@CR8]\] that can predispose offspring to anemia \[[@CR9], [@CR10]\]; maternal obesity could reduce the iron store of newborn \[[@CR11]--[@CR14]\] that likely leads to anemia in later life \[[@CR15]\]. However, direct assessment of the association between maternal obesity and offspring anemia is lacking.

On the other hand, underweight is also common in women of reproductive age in low/middle-income countries \[[@CR16]\]. Maternal underweight has also been reported to increase maternal anemia during pregnancy \[[@CR17], [@CR18]\], likely predispose offspring to anemia. Again, no prior study has examined the association of maternal underweight with offspring anemia.

Comprehensive assessment of the association between maternal body mass index (BMI) and infant anemia is crucial for optimal periconceptional counseling regarding offspring health, especially given that as high as 273 million children under 5 years globally were afflicted with anemia \[[@CR19]\], which can lead to irreversible health impairments \[[@CR20], [@CR21]\].

Therefore, we conducted this prospective cohort analysis to 1) describe the relationship between maternal BMI during early pregnancy and infant hemoglobin at 6 months and 12 months; 2) investigate whether maternal obesity or underweight is associated with infant anemia risk; 3) and assess whether the association (if exist) is mediated or modified by maternal anemia during mid-pregnancy.

Subjects and methods {#Sec2}
====================

Study subjects {#Sec3}
--------------

The cohort was drawn from a randomized controlled trial that was conducted in five counties in Hebei Province of northern China during 2006--2009, and all data were recorded in a perinatal and child health care surveillance system. Details of the trial have been described previously \[[@CR22]\]. Briefly, nulliparous women were recruited from public clinics during their prenatal care; those with moderate or severe anemia (hemoglobin \< 10.0 g/dl) were excluded. The 18,775 women were randomly assigned to receive daily folic acid, iron-folic acid, or multiple micronutrients from enrollment to delivery. For the present analysis, 1027 women were first excluded for moving out of the study region (*n* = 28), induced/ spontaneous abortion (*n* = 815), dropped out (*n* = 33), maternal death (*n* = 2), stillbirth (*n* = 82), or multiple pregnancies (*n* = 67). Among the remained 17,748 women who delivered single live births, 555 pregnant women were further excluded due to missing information on hemoglobin during mid-pregnancy (*n* = 115), missing their infants' information on hemoglobin at 5--7 months (*n* = 251) or at 11--13 months (*n* = 189). Finally, 17,193 mother-infant pairs (91.6%) were left in the final analyses (Fig. [1](#Fig1){ref-type="fig"}). Maternal and infant characteristics between mother-infant pairs included (*n* = 17,193) and the excluded (*n* = 1582) did not differ, except for maternal age, occupation, maternal BMI, and infants' sex, birth weight, and gestational age (*P* \< 0.05). Maternal BMI was statistically comparable across supplement groups in the trial, and micronutrient supplementation was not related to maternal weight in the present study. Fig. 1Flow chart of the mother-infant cohort

Exposure and outcomes {#Sec4}
---------------------

Women's weight and height wearing light indoor clothing and no shoes were measured by trained healthcare providers at enrollment before 20 weeks of gestation. Weight was measured to the nearest 50 g using an electronic scale (BW 150, UWE, Beijing, China) and height to the nearest 0.1 cm using a collapsible height board. The exposure in this study was BMI in early pregnancy of ≤12 gestational weeks. The early pregnancy BMI was calculated separately for women enrolled ≤12 gestational weeks and those enrolled during 13--20 gestational weeks. For women enrolled during 13--20 gestational weeks, weight in the first trimester was extrapolated using a standard formula: weight at enrollment -- (gestational week at enrollment -- 12 weeks) × 0.56 kg/week (the rate of gestational weight gain \[GWG\] in the second trimester for Asians) \[[@CR23]\]. BMI during early pregnancy was calculated as first-trimester weight in kilograms divided by the square of height in meters. According to the World Health Organization (WHO) guidelines for Asians \[[@CR24]\], maternal BMI was categorized as underweight, \< 18.5 kg/m^2^; normal weight, 18.5--22.9 kg/m^2^; overweight, 23.0--27.4 kg/m^2^; and obesity, ≥ 27.5 kg/m^2^.

Maternal and infant hemoglobin levels were measured using a HemoCue photometric instrument (Model 201; HemoCue, Ängelholm, Sweden). Outcomes of interest in this study were infant hemoglobin levels measured at 5--7 months (mean: 6.3 months) and 11--13 months (mean: 12.3 months) and infant anemia which was defined as hemoglobin \< 11.0 g/dl according to WHO recommendation \[[@CR25]\].

Information on relevant covariates was also retrieved from the perinatal and child health care surveillance system.

Statistical analysis {#Sec5}
--------------------

Categorical variables were presented as number (proportions), and continuous variables as mean (standard deviation, SD) or median (interquartile range, IQR). Chi-squared test was used to examine differences across maternal BMI groups for categorical variables, and analysis of variance or Kruskal-Wallis test for continuous variables.

Fractional polynomial model with generalized linear regression was used to examine the relation between maternal BMI and infant hemoglobin levels \[[@CR26], [@CR27]\], and joinpoint regression was applied to identify the potential breakpoints of the relation and to estimate respective regression coefficients. Logistic regression was used to estimate crude and adjusted odds ratios (ORs) of infant anemia across maternal BMI groups, with normal weight group as the reference. Adjusted covariates included maternal age (as a continuous variable), education status (primary school or less, middle school, and high school or above), ethnicity (Han or others), occupation (farmers or others), micronutrient supplementation (folic acid, iron-folic acid, and multiple micronutrients), anemia during mid-pregnancy (hemoglobin \< 11.0 g/dl or not during pregnancy) \[[@CR28]\], gestational week when hemoglobin was measured during pregnancy (as a continuous variable), rate of GWG in the second/third trimester (calculated by the difference between the last weight before delivery and the weight during early pregnancy and divided by gestational week, and then classified into quintiles within each BMI group), and infants' sex (male or female), gestational age (\< 37 or ≥ 37 weeks), mode of delivery (vaginal delivery, elective cesarean, and emergency cesarean), birth weight (\< 2500, 2500--3999, and ≥ 4000 g), feeding mode (exclusively breast-feeding, most breast-feeding, partly breast-feeding, and formula feeding), and age of infant at hemoglobin measurement (as a continuous variable). Mediation and stratified analyses were further performed to examine whether maternal anemia during mid-pregnancy which was likely linked to offspring anemia \[[@CR29]\], was a mediator or modifier for the association between maternal obesity and infant anemia.

To inspect the robustness of the results, the analyses regarding association of maternal obesity with offspring anemia were repeated either by using BMI cutoffs for western populations recommended by the WHO: underweight (\< 18.5 kg/m^2^), normal weight (18.5--24.9 kg/m^2^), overweight (25.0--29.9 kg/m^2^), and obesity (≥ 30.0 kg/m^2^) \[[@CR30]\], or by using the decile of maternal BMI as the classification criterion.

All analyses were performed using SPSS 24.0 (IBM Corp., Armonk. NY, USA), and a two-sided *P* \< 0.05 was considered statistically significant.

Results {#Sec6}
=======

Among the 17,193 mother-infant pairs, the median (IQR) maternal BMI during early pregnancy was 21.5 (20.0, 23.3) kg/m^2^, mean (SD) gestational age 38.9 (1.6) weeks, and mean birth weight 3297.6 (386.0) g; 16,988 (98.8%) were Han ethnicity and 15,644 (91.0%) farmers; 16,919 (98.4%) received a middle school education or above. Underweight, normal weight, overweight and obese mothers were 1507 (8.8%), 10,829 (63.0%), 4124 (24.0%), and 733 (4.2%), respectively. Infants born to obese mothers were more likely to be males, to have small gestational age and large birth weight, and to be born by cesarean delivery (Table [1](#Tab1){ref-type="table"}). Table 1Maternal and infant characteristics according to maternal BMI during early pregnancy ^a^CharacteristicUnderweight (*n* = 1507)Normal weight (*n* = 10,829)Overweight (*n* = 4124)Obesity (*n* = 733)*P***Mother** Age (years)23.1 ± 2.423.5 ± 2.624.0 ± 3.224.4 ± 3.7\< 0.001^\*^ Weight (kg)47.1 (45.0, 50.0)55.0 (51.9, 57.55)63.0 (60.1, 66.45)76.3 (72.3, 81.2)\< 0.001^\*^ Height (cm)160.0 (158.0, 164.0)160.0 (157.0, 163.0)160.0 (157.0, 162.0)160.0 (157.0, 163.0)\< 0.001^\*^ Early pregnancy BMI (kg/m^2^)17.8 (17.2, 18.2)20.9 (19.9, 21.9)24.2 (23.5, 25.3)29.3 (28.3, 31.0)\< 0.001^\*^ Rate of gestational weight gain (kg/week)0.6 ± 0.20.5 ± 0.20.4 ± 0.20.4 ± 0.2\< 0.001^\*^ Micronutrient supplementation0.709  Folic acid515 (34.2)3610 (33.3)1385 (33.5)227 (31.0)  Iron-folic acid505 (33.5)3613 (33.4)1388 (33.7)244 (33.3) Multiple micronutrients487 (32.3)3606 (33.3)1351 (32.8)262 (35.7) Education status\< 0.001^\*^  Primary school or less29 (1.9)148 (1.4)75 (1.8)22 (3.0)  Middle school1202 (79.8)8719 (80.5)3268 (79.2)617 (84.2) High school or above276 (18.3)1962 (18.1)781 (19.0)94 (12.8) Han ethnicity1490 (98.9)10,710 (98.9)4067 (98.6)721 (98.4)0.341 Farmer occupation1348 (89.5)9864 (91.1)3742 (90.7)690 (94.1)0.003^\*^Anemia during mid-pregnancy119 (7.9)670 (6.2)256 (6.2)37 (5.1)0.033^\*^**Infant** Male sex767 (50.9)5712 (52.8)2137 (51.8)404 (55.2)0.206 Birth weight (g)3193.1 ± 353.43280.1 ± 368.73354.5 ± 407.63448.1 ± 474.9\< 0.001^\*^ Gestational age (weeks)39.0 ± 1.638.9 ± 1.638.8 ± 1.738.7 ± 1.8\< 0.001^\*^ Mode of vaginal delivery863 (57.3)5921 (54.7)1781 (43.2)210 (28.7)\< 0.001^\*^ Feeding mode0.176  Exclusively breast-feeding480 (31.9)3440 (31.8)1249 (30.3)231 (31.5)  Most breast-feeding364 (24.1)2471 (22.8)1005 (24.4)176 (24.0)  Partly breast-feeding549 (36.4)4044 (37.3)1522 (36.9)251 (34.2)  Formula feeding89 (5.9)667 (6.2)263 (6.4)51 (7.0)  Missing25 (1.7)207 (1.9)85 (2.0)24 (3.3)^a^ Unadjusted means ± SDs or median (IQR) were computed for continuous variables, and number (proportions) for categorical variables^\*^*P* \< 0.05 (Chi-squared test for categorical variables, and analysis of variance or Kruskal-Wallis test for continuous variables)

Maternal BMI and infant hemoglobin {#Sec7}
----------------------------------

The median (IQR) hemoglobin levels were 12.2 (11.6, 12.8) and 12.2 (11.7, 12.8) g/dl for infants at 6 months and 12 months, respectively. Fractional polynomial regression showed an inverse U-shaped relation between maternal BMI during early pregnancy and hemoglobin levels for infants both at 6 and 12 months (*P values* \< 0.01 for nonlinearity, power *p* = − 2 and q = − 2), with an apex at 22.4 (95% CI 21.6, 23.2) kg/m^2^ of maternal BMI for 6-month old infants, and 22.6 (95% CI 21.6, 23.6) kg/m^2^ for 12-month old infants (Fig. [2](#Fig2){ref-type="fig"}). That is, hemoglobin levels tended to be lower in infants born to mothers with both low and high BMI, indicating a potential positive relation between maternal BMI and infant hemoglobin when BMI was less than 22.4 kg/m^2^, and a negative relation otherwise (Table [2](#Tab2){ref-type="table"}). Fig. 2Relations of maternal BMI during early pregnancy with infant hemoglobin levels; hemoglobin levels, solid lines; 95% CIs, broken lines. **a** Relation of BMI during early pregnancy with hemoglobin for infants at 6 months. **b** Relation of BMI during early pregnancy with hemoglobin for infants at 12 monthsTable 2Regression coefficients (95% CI) estimated by segmented regressionMaternal BMI during early pregnancy*β*^a^SE95% CIInfant at 6 months BMI \< 22.4 kg/m^2^0.028^\*^0.0060.017, 0.039 BMI ≥ 22.4 kg/m^2^−0.024^\*^0.005−0.033, −0.015Infant at 12 months BMI \< 22.6 kg/m^2^0.021^\*^0.0050.011, 0.032 BMI ≥ 22.6 kg/m^2^−0.018^\*^0.004−0.027, −0.010^a^ Regression coefficient was estimated by joinpoint regression^\*^*P* \< 0.01

Maternal obesity and infant anemia {#Sec8}
----------------------------------

Overall prevalence of infant anemia was 6.8% (1160/17193) at 6 months and 5.3% (904/17193) at 12 months. In crude analyses, maternal obesity was associated with increased risk of infant anemia at 6 months (OR 1.41, 95% CI 1.08, 1.84), but not at 12 months (OR 0.94, 95% CI 0.66, 1.33). The ORs were not materially changed after controlling for covariates, regardless of whether GWG rate, mode of delivery, birth weight, and maternal anemia during mid-pregnancy were controlled or not (Table [3](#Tab3){ref-type="table"}). Mediation analysis did not find that maternal anemia in mid-pregnancy mediate the association of maternal obesity with infant anemia at 6 months (Z = − 1.102, *P* = 0.270) (Additional file [1](#MOESM1){ref-type="media"}, Fig. S1). In analysis stratified by maternal anemia in mid-pregnancy, we observed no significant interaction between maternal anemia and BMI (*P*~-interaction~ = 0.130), while maternal anemia in mid-pregnancy appeared to augment the risk of infant anemia at 6 months (adjusted OR 2.91, 95% CI 1.14, 7.46) (Additional file [2](#MOESM2){ref-type="media"}: Table S1). Table 3Crude and adjusted ORs (95% CI) of infant anemia for maternal BMI during early pregnancyInfant anemiaEarly pregnancy BMI, *n* (%)UnderweightNormal weightOverweightObesityAnemia at 6 months ^a^107 (7.1)688 (6.4)301 (7.3)64 (8.7)Crude OR1.13 (0.91, 1.39)1.00**1.16 (1.01**, **1.34)**^**\***^**1.41 (1.08**, **1.84)**^**\***^***Adjusted OR***^***b***^***1.14 (0.90, 1.44)**1.00**1.19 (1.02, 1.39)***^***\****^***1.45 (1.08, 1.95)***^***\****^Adjusted OR ^c^1.14 (0.90, 1.44)1.00**1.17 (1.00, 1.37)**^**\***^**1.40 (1.04**, **1.89)**^**\***^Adjusted OR ^d^1.08 (0.85, 1.37)1.001.15 (0.98, 1.35)**1.39 (1.02**, **1.88)**^**\***^Anemia at 12 months ^a^85 (5.6)549 (5.1)235 (5.7)35 (4.8)Crude OR1.12 (0.89, 1.42)1.001.13 (0.97, 1.32)0.94 (0.66, 1.33)***Adjusted OR***^***b***^***1.02 (0.78, 1.34)**1.00**1.13 (0.94, 1.34)**1.01 (0.70, 1.48)***Adjusted OR ^c^1.04 (0.80, 1.37)1.001.12 (0.94, 1.33)0.98 (0.67, 1.43)Adjusted OR ^d^1.02 (0.78, 1.34)1.001.11 (0.93, 1.33)0.99 (0.68, 1.45)^a^ The proportions were calculated for infant anemia^b^ Adjusted covariates were maternal age, ethnicity, education status, occupation, micronutrient supplementation, and infant's sex, gestational age, feeding mode, and age of infant at hemoglobin measurement^c^ Additionally adjusted for rate of gestational weight gain, mode of delivery, and birth weight^d^ Further adjusted for mid-pregnancy anemia and gestational week when hemoglobin was measured during pregnancy^\*^*P* \< 0.05

The analyses regarding association of maternal obesity with infant anemia at 6 months were repeated using BMI cutoffs for western populations recommended by the WHO \[[@CR30]\], and the pattern was similar. However, a significantly increased risk of infant anemia at 6 months was observed for maternal overweight (adjusted OR 1.30, 95% CI 1.06, 1.60) rather than obesity (adjusted OR 1.39, 95% CI 0.87, 2.24), likely due to an inadequate sample size (*n* = 279) in the obese group (Additional file [2](#MOESM2){ref-type="media"}: Table S2). When women were reclassified ten subgroups (Q1 -- Q10) with Q7 (22.2--22.9 kg/m^2^) as the reference group, results were not materially changed (Additional file [2](#MOESM2){ref-type="media"}: Table S3).

Maternal underweight seemed not to increase anemia risk for infants at 6 months (adjusted OR 1.08, 95% CI 0.85, 1.37) or 12 months (adjusted OR 1.02, 95% CI 0.78, 1.34) in this well-nourished population that did not include women with moderate or severe anemia (Table [3](#Tab3){ref-type="table"}).

Discussion {#Sec9}
==========

In this Chinese birth cohort, we found an inverse U-shaped relation between maternal BMI during early pregnancy and hemoglobin levels for infants at 6 months, persisting till 12 months. When hemoglobin levels were dichotomized, maternal obesity was associated with a 39% increased anemia risk for infants at 6 months but not 12 months. Analyses were repeated using BMI criteria for western population to define overweight and obesity, and results were not materially changed, indicating the robustness of the findings. Relevant results for 12-month old infant anemia were not statistically significant, probably due to weakening impacts of prenatal factors or manifesting impacts of postnatal factors (e.g. complementary foods or treatment of infant anemia at 6 months). We further found that maternal anemia during mid-pregnancy, though it linked to offspring anemia \[[@CR29]\], aggravated the anemia risk for 6-month old infants, but did not mediated the association between maternal obesity and infant anemia at 6 months. Concerning maternal underweight, it seemed not to increase infant anemia risk in this relatively well-nourished population that excluded women with moderate or severe anemia.

Although no previous studies have assessed the relation of maternal BMI with offspring hemoglobin or anemia, some studies examined its relation with iron-related indices in cord blood \[[@CR11]--[@CR14]\]. Two prospective studies with a sample of \< 316 mother-infant pairs from the United States showed a negative linear relation between maternal BMI at delivery and plasma ferritin in umbilical cord blood \[[@CR11], [@CR13]\]. A case-control study from the United States showed a negative relation between maternal BMI before pregnancy and iron status in cord blood, including serum iron and transferrin saturation \[[@CR14]\]. The fourth study from China, a prospective analysis of 1613 mother-infant pairs, showed again a negative association of maternal BMI before pregnancy with cord blood ferritin levels \[[@CR12]\]. These previous studies consistently showed that women with higher BMI were more likely to deliver neonates with lower iron stores at birth.

Additionally, the inverse U-shaped relation could also lend support from biological pathways. Low maternal BMI is often related to various micronutrient deficiencies including iron, vitamin A or B6 \[[@CR31], [@CR32]\]. These deficiencies interfere with iron mobilization and utilization in the process of hemoglobin synthesis to increase maternal anemia risk \[[@CR33], [@CR34]\] and then to increase offspring anemia risk \[[@CR29]\]. On the other hand, high maternal BMI is regarded as a chronic inflammation status \[[@CR35]\] which could lead to an increasing level of hepcidin, a crucial hormone regulating iron metabolism \[[@CR36], [@CR37]\]. The higher hepcidin level in blood might result in less iron absorption in intestine, less iron storage in hepatocytes, and less iron release from splenic macrophages \[[@CR14]\], leading to low iron levels in mothers and consequently low iron stores in newborns \[[@CR38]\]. In addition, women with high BMI are more likely to deliver a baby by cesarean \[[@CR39]\] that affects placental transfusion or bacterial richness in newborns \[[@CR40]\], leading to low hemoglobin levels in cord blood \[[@CR41]\] or restricting dietary iron absorption and retention after birth \[[@CR42]\].

Our study has some limitations. Firstly, this study was conducted within a randomized clinical trial of prenatal micronutrient supplementation that excluded women with a hemoglobin \< 10.0 g/dl, likely restricting the generalization of our results to women with moderate or severe anemia during the first trimester of pregnancy. Secondly, two-thirds of the participants were provided with iron-containing supplementation, but the study design ensured that supplementation type was not associated with maternal BMI. Besides, we did not show a significant interaction between early pregnancy BMI and supplementation type (*P*~-interaction~ = 0.220; Additional file [2](#MOESM2){ref-type="media"}: Table S4). Thus, the associations were not likely biased by the provision of supplementation, but they do not necessarily apply to populations in which extensive supplementation is routine. Thirdly, the excluded women were more likely to have a higher BMI as compared to those included; if high BMI was associated with a higher risk of infant anemia, our estimate of the association between maternal BMI and infant anemia was likely underestimated. Fourthly, data on diet, physical activity and complications during pregnancy, as well as duration of breastfeeding were not recorded. In addition, the sample size in some subgroups might be insufficient, potentially affecting the robustness of the results in stratified analysis. Our study also has several strengths. To the best of our knowledge, this is the first study to investigate the relations of maternal BMI during early pregnancy with offspring hemoglobin levels and anemia risk. Infant hemoglobin and maternal key variables including maternal height, weight and hemoglobin were all measured by trained healthcare providers using unified equipment. Information on all incorporated covariates was from a surveillance system.

Conclusions {#Sec10}
===========

In summary, the relation between maternal BMI during early pregnancy and infant hemoglobin is inversely U-shaped, with an apex at 22.4 (95% CI 21.6, 23.2) kg/m^2^ of maternal BMI in 6-month old infants. Maternal obesity was associated with an increased risk of infant anemia at 6 months, which seems to be aggravated by maternal anemia during pregnancy. Our study enriched the epidemiological evidence on the adverse effect of high maternal BMI on long-term health of offspring. More studies in other populations should be conducted to confirm or refute our findings.

Supplementary information
=========================

 {#Sec11}

**Additional file 1 Fig. S1**. Summary of mediation analysis. The a and S~a~ respectively represent logistic regression coefficients and corresponding standard errors in relation of maternal BMI to maternal anemia, and the b and S~b~ respectively represent logistic regression coefficients and corresponding standard errors in relation of maternal anemia to infant anemia at 6 months. **Additional file 2 Table S1**. Adjusted ORs (95% CI) of infant anemia, stratified by maternal anemia during mid-pregnancy. **Table S2**. Crude and adjusted ORs (95% CI) of 6-month old infant anemia, using cutoffs for western population. **Table S3**. Crude and adjusted ORs (95% CI) of infant anemia for maternal BMI during early pregnancy categorized by deciles. **Table S4**. Adjusted ORs (95% CI) of 6-month old infant anemia, stratified by supplementation type.
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